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Abstract
Within systemic lupus erythematosus (SLE) patients can be divided into groups with and without central nervous system
involvement, the latter being subcategorized as neuropsychiatric systemic lupus erythematosus (NPSLE). While a number of
research groups have investigated NPSLE, there remains a lack of consistent application of this diagnostic criteria within
neuroimaging studies. Previous neuroimaging research suggests that SLE patients have reduced subcortical and regional
gray matter volumes when compared to controls, and that these group differences may be driven by SLE patients with
neuropsychiatric symptoms. The current study sought to compare measures of cortical thickness and subcortical structure
volume between NPSLE, SLE, and healthy controls. We hypothesized that patients with NPSLE (N=21) would have thinner
cortex and reduced subcortical gray matter volumes when compared to SLE (N=16) and control subjects (N=21). All
subjects underwent MRI examinations on a 1.5 Tesla Siemens Sonata scanner. Anatomical reconstruction and segmentation
were performed using the FreeSurfer image analysis suite. Cortical and subcortical volumes were extracted from FreeSurfer
and analyzed for group differences, controlling for age. The NPSLE group exhibited decreased cortical thickness in clusters
of the left frontal and parietal lobes as well as in the right parietal and occipital lobes compared to control subjects.
Compared to the SLE group, the NPSLE group exhibited comparable thinning in clusters of the frontal and temporal lobes.
Controlling for age, we found that between group effects for subcortical gray matter structures were significant for the
thalamus (F=3.06, p=.04), caudate nucleus (F=3.19, p=.03), and putamen (F=4.82, p=.005). These results clarify previous
imaging work identifying cortical atrophy in a mixed SLE and NPSLE group, and suggest that neuroanatomical abnormalities
are specific to SLE patients diagnosed with neuropsychiatric symptoms. Future work should help elucidate the underlying
mechanisms underlying the emerging neurobiological profile seen in NPSLE, as well as clarify the apparent lack of overlap
between cortical thinning and functional activation results and other findings pointing to increased functional activation
during cognitive tasks.
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Introduction
Neuropsychiatric systemic lupus erythematosus (NPSLE) is highly
prevalent in and increases significantly the morbidity and mortality
of patients with SLE [1,2,3,4]. In 1999, the American College of
Rheumatology developed 19 discrete neuropsychiatric syndromes
that comprised NPSLE, spanning both central (e.g., cerebrovascular
disease) and peripheral (e.g., neuropathy) nervous systems [5]. This
nomenclature has since been validated in several subsequent studies
of prospective patient cohorts [6,7,8,9,10]. However, no ‘‘gold
standard’’ currently exists by which to discriminate NPSLE with
high sensitivity and specificity despite a combination of behavioral
(e.g.,cognitivedysfunction),radiological(e.g.,ischemicchanges),and
laboratory findings (e.g., cytokine production) [11].
A number of research groups have undertaken imaging of
NPSLE, with hope of providing much needed specificity of central
nervous system involvement within SLE. Overt lesions and
metabolic abnormalities observed with Magnetic Resonance
Imaging may occur in 25 to 75% of NPSLE patients and are
positively associated with disease severity, disease activity, age, and
neurologic events [12,13,14,15,16,17,18,19,20,21,22,23]. Lesions
identified on MRI are attributed to in situ thrombosis, vasculitis,
edema, hemorrhage, atherosclerosis, or atheroembolism [24]. In
the first prospective study to assess MRI and postmortem tissue in
NPSLE, Sibbitt et al. studied 14 subjects characterized by the
ACR nomenclature and case definitions for NPSLE [24]. The
findings of this study supported previous prevalence studies of
brain abnormalities in NPSLE, showing small punctate focal
lesions in white matter being the most common MRI finding
(100%), followed by cortical atrophy (64%), ventricular dilation
(57%), cerebral edema (50%), diffuse white matter abnormalities
(43%), focal atrophy (36%), cerebral infarction (29%), acute
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[13,14,15,16,21].
Cerebral atrophy has been demonstrated repeatedly in SLE
using both Computed Tomography (CT) and Magnetic Reso-
nance Imaging (MRI). However, prevalence rates vary widely
due to different imaging modalities, different patient selection
criteria, and the prevalence of qualitative (as opposed to
quantitative) assessments [23,25,26,27,28,29,30,31,32,33,34]. To
date, only one study has attempted to use automated analysis
methods to assess cortical atrophy in SLE [35]. This group
studied eighty-nine patients diagnosed with SLE and used Voxel-
Based Morphometry (VBM) to assess gray and white matter
volume differences compared to forty-four healthy controls. They
specifically excluded two subjects with history of stroke. Patients
with active central nervous system involvement (48%) were
compared to those without such involvement using the ACR
guidelines [5]. Results indicated reduced gray matter volumes in
SLE patients compared to controls in frontal, occipital, and
temporal lobes as well as in limbic areas; patients with CNS
involvement (i.e., NPSLE) were driving this relationship, as SLE
patients without CNS involvement were not significantly different
from controls [35].
Cortical atrophy is apparent in SLE on standard CT and MRI
images, and volume differences have been demonstrated in
widely distributed brain regions using automated segmentation
techniques [35]. We sought to use a complementary, semi-
automated, segmentation technique that accurately measures
cortical thickness and specific subcortical structure volume
[36,37] as opposed to gray matter volume [38,39,40]. We assess
group cortical thickness and subcortical gray matter volume
differences between NPSLE, SLE, and age-and-gender matched
healthy volunteers. As the previous VBM study did not control
for age [35], we also aim to control for any contribution of age
effects on cortical thickness and subcortical gray matter
reductions in this cohort. We hypothesized that, after controlling
for age, patients diagnosed with NPSLE would have thinner
cortex and reduced subcortical gray matter volumes than patients
without NPSLE or control subjects.
Results
Demographic data
NPSLE, SLE, and Control subjects did not differ significantly in
terms of age (F=1.31, p=2.78; NPSLE=39.2+/212.5;
SLE=37.3+/212.6; controls =33.2+/211.6), gender (%, %,
and % females, respectively) and premorbid intellectual function-
ing (F=.40, p=.67; NPSLE=44.9+/27.1; SLE=46.0+/28.0;
controls =47.0+/27.09).
Clinical, laboratory and treatment features
Six NPSLE patients had past stroke (two had current stroke);
twelve patients had past TIA (three had current TIA); no patients
had past or current acute psychosis; four patients had past seizure
disorder (four had current seizure disorder); five patients had past
acute confusional state (one patient had current acute confusional
state); five patients had past moderate or severe cognitive
dysfunction (one patient had current moderate or severe cognitive
dysfunction). Overall, twenty-one patients demonstrated either
acute or past (or both acute and past) symptoms of NPSLE. Mean
SLEDAI score at the time of MRI scan was 13.9 (range 3–43;
SD=11.2) for NPSLE and 9.1 (range 1–19; SD=5.8) for SLE. At
the dates of MRI, 42 % of patients were on steroid use. Mean
SLICC/ACR DI scores were 4.4 (range 0–9; SD=2.7) for NPSLE
and 2.1 (range 0–4; SD=1.2) for SLE.
Cortical Thickness Differences
Because controls were somewhat younger than either patient
group, and all groups had a wide age range (18–60), we first
examined the effects of age on cortical thickness across the entire
sample. We found that age had a significant effect on cortical
thickness across the group, with decreasing thickness associated
with increasing age in numerous brain regions (p,.05 corrected
for multiple comparisons using FDR)(Figure 1). There were no
brain regions in which increased age was associated with increased
cortical thickness. Interestingly, NPSLE, SLE, and control subjects
had different slopes and intercepts in various regions where age
effects were observed, suggesting an interaction between disease
processes and age (Figure 2).
We next assessed cortical thickness differences between NPSLE,
SLE, and control groups, controlling for age. We first assessed
differences between NPSLE and controls, and found numerous
regions in which NPSLE patients had thinner cortices compared
to controls (p,.01 uncorrected). Regions which survived FDR
statistical correction (light blue) (p,.05), included the postcentral,
supramarginal, rostralmiddle frontal, and precuneus gyri in the left
hemisphere, and the inferior parietal and postcentral gyri in the
right hemisphere(Figure 3).
When SLE patients were compared to control subjects, there
were small scattered clusters in which patients had increased or
decreased cortical thickness. None survived FDR correction
(Figure 4).
We next assessed differences between NPSLE and SLE patients,
and found numerous regions in which NPSLE patients had
thinner cortices compared to SLE patients (p,.01 uncorrected).
Regions which survived FDR statistical correction (light blue)
(p,.05), included the rostralmiddle frontal, superior frontal,
superior temporal, inferior temporal, and lateral occipital gyri in
the right hemisphere (Figure 5). No regions survived FDR
correction in the left hemisphere.
Finally, we assessed subcortical gray matter differences between
groups, focusing on the hippocampus, amygdala, caudate nucleus,
putamen, and thalamus. Controlling for age, we found that
between group effects were significant for the thalamus (F=3.06,
p=.04), caudate nucleus (F=3.19, p=.03), and putamen
(F=4.82, p=.005). Post hoc analyses showed that NPSLE subjects
had lower volumes compared to controls within the thalamus
(t=2.53, p=.016) and putamen (t=2.05, p=.05). No regions
were significantly different between SLE and control subjects in
post hoc analyses.
Discussion
We found that young patients with NPSLE had lower cortical
thickness in several regions of the brain compared to both SLE
patients without past or current NPSLE and normal controls.
These results clarify previous imaging studies showing cortical
atrophy in SLE [23,24,25,26,27,28,30,31,32,33,34,41,42,43].
Indeed, the only study using automated segmentation techniques
noted that ‘‘no difference between SLE patients without CNS
involvement and healthy controls was observed’’ [35]. This
conforms well with our data showing significant gray matter
reductions in NPSLE, but not SLE, compared to control subjects.
However, our study suggests that cortical thickness on MRI
separates patients with NPSLE from those without NPSLE and
healthy controls.
The regions in which we observed significant reductions of gray
matter in NPSLE compared to control subjects were within the
postcentral, supramarginal, rostralmiddle frontal, and precuneus
gyri in the left hemisphere, and the inferior parietal and
Cortical Thickness in NPSLE
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patients differed from SLE patients included the rostralmiddle
frontal, superior frontal, superior temporal, inferior temporal, and
lateral occipital gyri in the right hemisphere and there was no
overlap in regions where NPSLE differed from SLE or controls. In
comparing the regions in which NPSLE differed from controls,
there appears to be commonality with those identified by
Appenzeller et al., [34], particularly the left precuneus. The
precuneus has been implicated in visuo-spatial imagery, episodic
memory retrieval, perspective taking, and the experience of
‘‘agency’’ [44]. Moreover, the precuneus has rich cortical and
subcortical connections [45] with other regions found to have
reduced cortical thickness in NPSLE including the thalamus [46],
inferior parietal lobule (i.e., supramarginal gyrus), and postcentral
gyri.
Subcortically, we found significantly reduced gray matter
volume in the thalamus, caudate, and putamen in NPSLE. the
thalamus of which was also found to be reduced in volume in the
prior VBM study [35]. Other studies have shown thalamus
abnormalities with measures of fractional anisotropy [47] and
glucose metabolism [48] in patients diagnosed with NPSLE and
SLE respectively. We did not find significant hippocampal size
reductions in our sample of NPSLE and SLE patients, as has been
previously reported [49], although our sample size is significantly
smaller than that reporting differences. However, our data suggests
that NPSLE patients had smaller hippocampi than SLE patients,
who had smaller hippocampi than controls. Futures studies with
larger samples should elicit significant differences as demonstrated
previously.
One significant difference between our study and the previous
VBM study was that ours included NPSLE patients suffering from
past or current cerebrovascular accident. Other imaging studies in
SLE have included patients with stroke [18,27,30,32], and there is
significant overlap between patients with antiphospholipid syn-
drome, stroke, and epileptic seizures [50]. As the incidence of
stroke in SLE has been found to be increased by a factor of 2.29 in
a population cohort [51], exclusion of these subjects in
neuroimaging studies would appear to limit generalizability of a
particularly debilitating neurological consequence of disease status.
Strengths of the current study include: 1) the relatively large
patient cohort, 2) the relative youth (,/=60 years) of the patient
cohort compared to previous studies, 3) whole brain as compared
to ROI analyses, 4) ease, reproducibility, and automaticity of
FreeSurfer methodology, and 5) the lack of differences between
SLE patients without NPSLE and controls strengthen the
specificity of our findings. A limitation of the study is the lack of
repeated measures of the acute NPSLE patients as they progress
through the acute phase of their disease. This would help to
establish whether therapy or disease characteristics predominated
over time in determining cortical and subcortical gray matter
Figure 1. Group comparison of cortical thickness relationships to age for the entire group of NPSLE, SLE, and control subjects
(N=58). Images show clusters of lower (blue clusters) cortical thickness values related to age. Clusters are displayed in the range of p#.01 to
p#.0001 (color scale shows 2log (10) p-value). Top left = left lateral hemisphere; Bottom left = left medial hemisphere; Top right = right lateral
hemisphere; Bottom right = right medial hemisphere. Light blue regions indicate regions where age and cortical thickness were significantly related
(p,.05) corrected for multiple comparisons (FDR).
doi:10.1371/journal.pone.0009302.g001
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PLoS ONE | www.plosone.org 3 March 2010 | Volume 5 | Issue 3 | e9302Figure 2. Scatterplot showing individual cortical thickness values (in millimeters) obtained from the left rostrofrontal cortex for the
sample. Red squares = NPLSE patients; Blue circles = SLE patients (blue circles); Black diamonds = control subjects, stratified by age. All three
groups show decreasing trends for cortical thickness in all significant regions (light blue in Figure 1).
doi:10.1371/journal.pone.0009302.g002
Figure 3. Group comparison of cortical thickness differences between NPSLE patients (N=21) and control subjects (N=21). Images
show clusters of lower (blue clusters) cortical thickness values controlling for age. Clusters are displayed in the range of p#.01 to p#.0001 (color scale
shows 2log (10) p-value). Clusters which survived FDR correction for multiple correction (p#.05 are encircled). Top left = left lateral hemisphere;
Bottom left = left medial hemisphere; Top right = right lateral hemisphere; Bottom right = right medial hemisphere.
doi:10.1371/journal.pone.0009302.g003
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difficult to study repetitively in the acute setting, and these data
would have likely increased the differences between acute NPSLE
as compared to SLE patients or healthy controls. Future studies
will determine if patients can be subcategorized into more
tractable groups amenable to sensitive neuroimaging studies.
These results suggest that great care is needed when selecting
NPSLE patients to participate in neuroimaging studies. Patients
with NPSLE appear to have different cortical and subcortical gray
matter thinning characteristics than those SLE patients without
acute or past NPSLE symptoms (e.g., seizure, transient ischemic
attack, acute confusion). It is important to include NPSLE patients
in studies (including those with stroke), as well as to determine the
brain mechanisms involved in order to better target therapeutic
approaches designed to reduce mortality and morbidity.
What functional significance might these volume reductions
have for NPSLE? Previous functional studies have demonstrated
reduced glucose metabolism [52], yet increased functional
activation on motor [53] and working memory tasks [54] in
NPSLE. Researchers have hypothesized ‘‘increased neural re-
cruitment’’ in patient cohorts in which equivalent behavioral
performance is observed, in the presence of disease, designed to
limit the functional impact of neuronal injury [55]. Other studies
in normal cohorts of children have found decreased cortical
thickness associated with increased functional activations [56,57].
Indeed, some of the regions in which increased ‘‘neural
recruitment’’ were observed during functional imaging studies
included the precuneus and putamen [53] and inferior parietal
and frontal polar regions [54]: similar regions in which our study
found decreased thickness in NPSLE subjects compared to
controls. While quite preliminary in nature, these findings add
to an emerging body of literature suggesting that brain structure
and function might not increase and decrease in tandem, but
might reflect a complex interplay of excitatory and inhibitory
networks designed to optimize functional capacity while consum-
ing minimal resources [58]. Future research in NPSLE presents a
particularly fruitful patient group by which various hypotheses’
regarding the complex interplay of brain structure and function at
various stages of disease might be undertaken.
Methods
Sample
This study was conducted according to the principles expressed
in the Declaration of Helsinki, and was approved by the
Institutional Review Board of the University of New Mexico. All
subjects provided written informed consent for the collection of
samples and subsequent analysis. The sample consisted of thirty-
seven SLE patients, recruited from the Rheumatology Clinics of
the University of New Mexico, ranging in age from 18 to 60 (35
females). All subjects were diagnosed with SLE based on the 1997
update to the 1982 American College of Rheumatology Revised
Figure 4. Group comparison of cortical thickness differences between SLE patients (N=16) and control subjects (N=21). Images
show clusters of higher (red clusters) and lower (blue clusters) cortical thickness values controlling for age. Clusters are displayed in the range of
p#.01 to p#.0001 (color scale shows 2log (10) p-value). No clusters survived FDR correction for multiple correction (p#.05). Top left = left lateral
hemisphere; Bottom left = left medial hemisphere; Top right = right lateral hemisphere; Bottom right = right medial hemisphere.
doi:10.1371/journal.pone.0009302.g004
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Twenty-one of the SLE patients had major NPSLE defined as
current or past stroke or transient ischemic attack (TIA), current or
past confusional state, moderate or severe cognitive dysfunction,
current or past seizures, or current or past psychosis. Sixteen
patients had SLE, but no current or past NPSLE.
These 2 groups of patients were compared to twenty-one
healthy controls (18 females). Participants were screened for
conditions that would prohibit undergoing an MRI scan (e.g.,
metal implant, orthodontic braces, severe claustrophobia).
Clinical Measures
The Systemic Lupus Erythematosus Disease Activity Index
(SLEDAI) [60] and Systematic Lupus International Collaborating
Clinics/America College of Rheumatology Damage Index
(SLICC/ACR DI) [61] were administered by an experienced
rheumatologist (WLS) to each patient. Clinical diagnosis of NPSLE
wasdefined bypresenceofpastorcurrent:stroke,transientischemic
accident, psychosis, seizure disorder, confusional state, and/or
moderate or severe cognitive dysfunction. No SLE patients had any
past or current evidence of any of these clinical diagnoses.
Behavioral Measure
The Wide Range Achievement Test – 3
rd Revision (WRAT-3)
Reading subtest, was used as a measure of premorbid cognitive
functioning. This measure requires subjects to read single words
with irregular phonetic spelling (e.g., colonel), and has been found
to be resistant to the effects of cognitive decline due to neurological
or psychiatric disease [62].
Image Acquisition and Processing
MR examinations were performed on a 1.5T Siemens Sonata
scanner using an 8-channel phased array head coil. Structural
imaging was obtained using a T1 coronal gradient echo sequence
[TE=4.76 ms; TR=12 ms; Voxel Size =16161.5 mm; acqui-
sition time =7:15]. Subjects’ heads were stabilized with tape
across the forehead and padding around the sides. For all scans,
each T1 was reviewed for image quality. Cortical reconstruction
and volumetric segmentation were performed with the FreeSurfer
image analysis suite, which is documented and freely available for
download online (http://surfer.nmr.mgh.harvard.edu/). The
methodology for FreeSurfer is described in full in several papers
[36,37,63,64,65,66,67,68,69,70,71]. For this paper, we are focused
on the cortical thickness results and volumes of select subcortical
structures. Procedures for the measurement of cortical thickness
have been validated against histological analysis [72] and manual
measurements [73,74]. The results of the automatic segmentations
were reviewed and any errors were corrected.
Statistical Analysis
To investigate the correlation between cortical thickness
measurements between groups (NPSLE, SLE, controls) we
Figure 5. Group comparison of cortical thickness differences between SLE patients (N=16) and NPSLE patients (N=21). Images show
clusters of lower (blue clusters) cortical thickness values controlling for age. Clusters are displayed in the range of p#.01 to p#.0001 (color scale
shows 2log (10) p-value). Clusters which survived FDR correction for multiple correction (p#.05 are encircled). Top left = left lateral hemisphere;
Bottom left = left medial hemisphere; Top right = right lateral hemisphere; Bottom right = right medial hemisphere.
doi:10.1371/journal.pone.0009302.g005
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FreeSurfer. First, the subjects’ surface was smoothed using a full-
width/half-maximum Gaussian kernel of 10 mm. This smoothing
was done so that all subjects in this study could be displayed on a
common template (an average brain as described at http://surfer.
nmr.mgh.harvard.edu/) in order to perform and visualize a group
analysis. Freesurfer’s mri glmfit was used to fit a general linear
model at each vertex in the cortex to perform between group
averaging and statistical inference on the cortical surface. The
design matrix consisted of three discrete groups, (NPSLE, SLE,
control), with age as a covariate; the slope used was different
offset/intercept, different slope (DODS). The contrast matrix used
investigated the average differences between cortical thickness,
while regressing out the effect of age, which was a two-tailed t-test,
with (NPSLE,SLE,control). We used similar statistical methods
that were used in prior thickness studies [58,75,76,77] to ascertain
surface-based group differences using the general linear model
tools within FreeSurfer. In order to correct for multiple
comparisons, we used False Discovery Rate (FDR) at p,.05.
We also show significant clusters at p,.01 uncorrected for
hypothesis generation in this initial study. Finally, we assessed
volumetric differences between groups for subcortical structural
regions including the hippocampus, amygdala, thalamus, caudate
nucleus, and putamen. Volumes were extracted from FreeSurfer
and analyzed with SPSS 13.0 using an ANCOVA controlling for
age. Group differences were assessed between NPSLE, SLE, and
controls using two-tail tests. Post hoc t-tests were used to determine
specific differences between groups (e.g., NPSLE vs. controls; SLE
vs. controls; NPSLE vs. SLE).
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